Table 3 Occurrence of decompensating event following viral eradication
|  | HCV/HIV co-infected (N = 11) | HCV mono-infected (N = 114) | ||
|---|---|---|---|---|
Patients with a pre-treatment history of decompensated cirrhosis | N. | % | N. | % |
Ascites | 6 | 85.7 | 32 | 52.5 |
Ascites + hepatic encephalopathy | 0 | 0.0 | 8 | 13.1 |
Ascites + gastrointestinal bleeding | 0 | 0.0 | 2 | 3.3 |
Ascites + gastrointestinal bleeding + hepatic encephalopathy | 0 | 0.0 | 2 | 3.3 |
Hepatic encephalopathy | 0 | 0.0 | 9 | 14.8 |
Gastrointestinal bleeding | 1 | 14.3 | 8 | 13.1 |
TOTAL | 7 | 100.0 | 61 | 100.0 |
Patients with incident decompensating event | N. | % | N. | % |
Ascites | 3 | 75.0 | 32 | 67.9 |
Ascites + hepatic encephalopathy | 0 | 0.0 | 6 | 3.8 |
Hepatic encephalopathy | 1 | 25.0 | 6 | 11.3 |
Gastrointestinal bleeding | 0 | 0.0 | 9 | 17.0 |
TOTAL | 4 | 100.0 | 53 | 100.0 |